I am Celia Pérez and I studied a FP in Clinical and Biomedical Laboratory (finished in 2022). Later I decided to study the FP in Pathological Anatomy and Cytodiagnosis (completed in 2023) at the IES Cantabria.
I did the internships for both studies in the Tissue Engineering Group at the Faculty of Medicine of the UC (University of Cantabria) under the direction of Flor Pérez Campo and that is where I discovered my passion for clinical research and the management of cell cultures, which prompted me to study a specialization course in cell cultures at the CIFP Camino la Miranda (Palencia) which I finished in 2024.
Once I finished the course I started working in the Department of Cellular and Molecular Signaling under the direction of Berta Casar at the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC).
Transformation and Metastasis
IBBTEC's Transformation and Metastasis group investigates signaling pathways involved in alterations during cancer and metastasis.
The ultimate goal of these studies is to identify modulators that may represent new therapeutic targets to curb metastasis and that can be directly translated into effective prevention or treatment strategies.
The group has a multidisciplinary approach and uses chick and mouse embryo models, organoids and 3D cultures, clinical samples and molecular and cellular biology techniques, patient-derived xenografts, to translate basic research into translational oncology and clinically relevant outcomes.
Funding
- Relevancia funcional de PTPk en la rutaRas-ERK: Implicaciones terapeúticas en melanoma. MICIN(CSIC). 01/01/2017- 31/12/2019. SAF 2015-73364-JIN
- Repurposing MAPK inhibitors for the treatment of COVID-19. Proyecto Intramural Especial PIE -CSIC ref 202020E113 15/04/2020-31/12/2023
- Bases moleculares de resistencia a quimioterapia en neuroblastoma: identificación de nuevos biomarcadores y dianas terapéuticas. PIE-CSIC. 23/01/2020-present MAPK inhibitors for the treatment of COVID-19. Proyecto Gobierno de Cantabria COVID-19 ORDEN UIC/22/2020. 1/11/2020
- Mecanismos moleculares que determinan la resistencia a quimioterapia en neuroblastoma. Berta Casar. Proyecto Intramural Especial PIE CSIC 201412 5 9. 1/06/2021- 31/05/2022
- Definir el mecanismo de activacion de CDCP1 para bloquear metastasis de cancer de mama triple negative. Proyectos de I+D+i. Retos de la Sociedad, del Plan Estatal de Investigación y de Innovación 2017-2020. Referencia PID2020-112760rb-i00. 1/09/2021- 31/8/2024
- Development of a therapeutic response marker for metastatic melanoma 1/12/2021- 30/11/2023 FERO XXI BFERO2103
- Investigación preclínica de nuevas terapias dirigidas en Linfoma Cutáneo de Células T. PRECLILINF Proyectos de I+D+i. Retos de la Sociedad, del Plan Estatal de Investigación y de Innovación 2024-2027.
